Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By white_Tiger (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Go Long Quality And Short The Junk [GeoWire Weekly No. 154]

% of readers think this story is Fact. Add your two cents.


Welcome to The GeoWire , your source for a Peek into GeoInvesting’s Research Coverage, Microcap Stock Education, Case Studies, Featured Videos, and More. Please share this if you like today’s newsletter and comment with any feedback.


If you are new or this was shared with you, you can join our email list here.

For real time analysis of our coverage universe, including new high conviction ideas and additions to our model portfolios, if you are not already a premium subscriber, consider supporting our movement by becoming a premium member today. GeoInvesting, 16 years and counting!

Highlights
  • The era of cheap money to return now just a memory
  • Still stressing that GARP investing in high quality microcaps is the future
  • Zombie index reinforces the “short the junk” theme. [Video]
  • Three must-see discussions – One with a respected peer, and two with management teams of trending microcap companies in GEO’s coverage universe. [Videos]

The big news last week was the Federal Reserve’s decision to slash the Fed’s funds rate by 50 basis points to a range of 4.75% to 5%.

Everyone’s talking about the magnitude of the cut and the implications for the stock market, especially for the Russell 2000 Small-cap Index, where it’s been demonstrated that smaller companies as a whole have more floating-rate debt on their balance sheets. However, they are missing the most important implication related to certain statements made by the Fed Chairman. These statements will have serious connotations for the microcap stocks that we cover in our 1500+ universe.

Among several comments that CNBC journalist Michelle Fox recently contributed to ongoing coverage of the September 18 fed meeting recap, ‘Chair Jerome Powell defends central bank’s decision to go big with first cut‘, she wrote:

“‘We are not going back’ to world of ultra-low interest rates

Federal Reserve Chair Jerome Powell does not expect the era of cheap money to return.

“Intuitively, most — many, many people anyway — would say we are probably not going back to that era where there were trillions of dollars of sovereign bonds trading at negative rates, long-term bonds trading at negative rates,” he said.

“My own sense is that we are not going back to that,” Powell added.

He feels the neutral rate is likely significantly higher than it was back then, although he does not know yet how high it is.”

Of course, I had to chime in with a thought or two of my own in response to her comment:

“This is so super bullish for quality, smaller cap…. I can’t begin to tell you how much. Long quality + short junk in small cap (that’s still around from the easy money days) will be in play for years. Game on!”

Jerome Powell’s recent comments illustrate a consistent theme he has been emphasizing over the past year: the era of “cheap money” is unlikely to return. Since the aftermath of the 2008 recession, as well as during the COVID-19 pandemic, the Federal Reserve adopted quantitative easing and ultra-low interest rates policies to stabilize the economy. Now, Powell has made it abundantly clear that this period, characterized by negative, near-zero or even extremely low interest rates, is behind us.

This was music to my ears. I was somewhat concerned that the bull market in high-quality stocks that began percolating in 2022 could eventually be threatened if the Fed decided to return to an ultra easy money policy.

Make no mistake – we have been pounding the table since mid-2022 that elevated interest rates (if sustained) will lead to a long-term bull market in smaller cap, high-quality companies not heavily reliant on external funding to grow or finance operations. Why? The access to “survival capital” has been closing for lower-quality companies and pump & dumps. 

It’s unfortunate that many investors, especially younger investors, that “fed” off the teet of the market during the 2009 to 2022 low quality bull market, still don’t understand that this period is not and was not the norm. 

I’m incredibly excited that we are finally entering a similar type of normalcy that existed in my first 20ish years as a full-time investor, where GARP-ish microcap investing was in play. Quite frankly, I was able to crush the market, even though I had to suffer a serious setback when the internet bubble blew up, one I was not sure I was  going to come back from. And then, there was 2008! But I will save that drama for another storytelling time.

The best evidence that good times are here for old-fashioned, quality, value investing or whatever you want to call it, is the performance of the MSMqi, the only index that qualifies a stock through a combination of quality and multi-bagger factors.

By the way, another great indicator that quality is here to stay, and that low-quality is going to get punished is an index our team created in 2023, called the “Zombie Index”, which I haven’t published anywhere yet. This index tracks the low quality, smaller cap stocks, based on certain criteria.  Here’s what that looks like (negative returns in short selling equate to positive returns on your capital):

Zombie Stocks Returns.

You can learn more about the Zombie Index in this clip from my Investor Insights Skull Session chat with Deep Sail Capital last week:

In a nutshell, the theme for many years to come will be long quality / short junk. Investors in the microcap space will need to focus on stock-picking.

There’s only so much money to go around in the market, and now, some of that money that was finding its way to low-quality companies during the easy money days is going to continue to make its way into the higher-quality microcap universe that we play in (a trend that began in 2022). 

For well-managed, undervalued microcaps with great fundamentals and a clear path to growth, the current environment could allow them to shine as capital becomes more selective. We also think the environment is fantastic for high-probability turnaround situations, where balance sheet restructurings or small tweaks in business plans put a company back on track for growth.

However, companies that rely heavily on external funding will continue to face headwinds. I’ve written on these bullish viewpoints over the years, so I dug a few of them up, showing that GeoInvesting has consistently been a champion for the resurgence in the leadership of quality microcaps under the right conditions as well as company-specific variables, even giving Canadian microcaps a plug, which, as intimated, have taken a major place in our coverage universe.

So this is probably a good time to pivot to three discussions I had last week, one with a peer, the Founder of Deep Sail Capital, and the management of two companies in our microcap coverage universe – Covalon Technologies Ltd. (OTC:CVALF) (TSX:COV) (wound care and infection control products) and Tss, Inc. (OTCQB:TSSI) (data center integration services). Needless to say, it was a busy but fulfilling week, and it took a bit of heavy lifting to have gotten ALL the conversations to you today.

Continue to watch these 3 full length videos.

The remainder of this post is only visible to paid subscribers of GeoInvesting.

Please don’t forget to consider supporting GeoInvesting with a premium subscription if you enjoyed this content, and want to see more of it. Complete this short survey to let us know you’re engaged and interested.

200+ Multibaggers and counting

 

The post Go Long Quality And Short The Junk [GeoWire Weekly No. 154] appeared first on GeoInvesting.


Source: https://geoinvesting.com/go-long-quality-and-short-the-junk/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.